Suresh Mallikaarjun

1.6k total citations
45 papers, 1.3k citations indexed

About

Suresh Mallikaarjun is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Suresh Mallikaarjun has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Pediatrics, Perinatology and Child Health and 13 papers in Molecular Biology. Recurrent topics in Suresh Mallikaarjun's work include Electrolyte and hormonal disorders (13 papers), Schizophrenia research and treatment (11 papers) and Ion Transport and Channel Regulation (8 papers). Suresh Mallikaarjun is often cited by papers focused on Electrolyte and hormonal disorders (13 papers), Schizophrenia research and treatment (11 papers) and Ion Transport and Channel Regulation (8 papers). Suresh Mallikaarjun collaborates with scholars based in United States, Spain and Japan. Suresh Mallikaarjun's co-authors include Steven L. Bramer, Susan E. Shoaf, Patricia Bricmont, Daniel E. Salazar, William P. Forbes, David W. Boulton, Leslie Citrome, Ryo Kubota, Zhao Wang and Robert A. Forbes and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Suresh Mallikaarjun

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by Suresh Mallikaarjun

Since Specialization

Citations

This map shows the geographic impact of Suresh Mallikaarjun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Mallikaarjun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Mallikaarjun more than expected).

Fields of papers citing papers by Suresh Mallikaarjun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Mallikaarjun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Mallikaarjun. The network helps show where Suresh Mallikaarjun may publish in the future.

Co-authorship network of co-authors of Suresh Mallikaarjun

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Mallikaarjun. A scholar is included among the top collaborators of Suresh Mallikaarjun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Mallikaarjun. Suresh Mallikaarjun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia 2021 ·PharmacoEconomics ·(unknown), Natalie Houwing, (unknown), Xiaofeng Wang, Heidi C. Waters, Ruth A. Duffy, Suresh Mallikaarjun, Craig Bennison	3
2	Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function 2013 ·Kidney International ·Susan E. Shoaf, Patricia Bricmont, Suresh Mallikaarjun	34
3	Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole 2012 ·Journal of Clinical Pharmacy and Therapeutics ·David W. Boulton, Georgia Kollia, Suresh Mallikaarjun, David M. Kornhauser	9
4	Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects 2012 ·European Journal of Clinical Pharmacology ·Susan E. Shoaf, (unknown), Patricia Bricmont, Suresh Mallikaarjun	26
5	SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR 2011 ·Retina ·Ryo Kubota, Nancy L. Boman, Robert David, Suresh Mallikaarjun, (unknown), David G. Birch	79
6	Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects 2011 ·European Journal of Clinical Pharmacology ·Susan E. Shoaf, Suresh Mallikaarjun, Patricia Bricmont	20
7	Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non‐peptide AVP antagonist in healthy subjects 2011 ·British Journal of Clinical Pharmacology ·Susan E. Shoaf, Patricia Bricmont, Suresh Mallikaarjun	60
8	In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects 2010 ·The Journal of Clinical Pharmacology ·Susan E. Shoaf, (unknown), Shinichi Ninomiya, Masayuki Furukawa, Patricia Bricmont, Eiji Kashiyama, Suresh Mallikaarjun	42
9	An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder 2009 ·Journal of Child and Adolescent Psychopharmacology ·Robert L. Findling, Ralph E. Kauffman, Floyd R. Sallee, Daniel E. Salazar, Vaishali Sahasrabudhe, Georgia Kollia, David M. Kornhauser, Nimish N. Vachharajani, Sheila Assunção-Talbott, Suresh Mallikaarjun, Taro Iwamoto, Robert D. McQuade, David W. Boulton, Jeffrey L. Blumer	38
10	A non‐randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady‐state pharmacokinetics of lamotrigine in patients with bipolar I disorder 2009 ·Human Psychopharmacology Clinical and Experimental ·(unknown), David W. Boulton, Alfred H. Balch, Robert Croop, Suresh Mallikaarjun, (unknown), Berit X. Carlson	12
11	Pharmacokinetics and Tolerability of Intramuscular, Oral and Intravenous Aripiprazole??in Healthy Subjects and in??Patients??with Schizophrenia 2008 ·Clinical Pharmacokinetics ·David W. Boulton, Georgia Kollia, Suresh Mallikaarjun, Bernard J. Komoroski, Anjali Sharma, (unknown), Richard A. Reeves	28
12	Effects of Hepatic or Renal Impairment on the Pharmacokinetics of Aripiprazole 2008 ·Clinical Pharmacokinetics ·Suresh Mallikaarjun, Susan E. Shoaf, David W. Boulton, Steven L. Bramer	31
13	Pharmacokinetics of Aripiprazole and Concomitant Carbamazepine 2007 ·Journal of Clinical Psychopharmacology ·Leslie Citrome, Jean-Paul Macher, Daniel E. Salazar, Suresh Mallikaarjun, David W. Boulton	43
14	Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single‐Dose Studies in Healthy Subjects 2007 ·The Journal of Clinical Pharmacology ·(unknown), Zhao Wang, Patricia Bricmont, Suresh Mallikaarjun	74
15	Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers 2004 ·The Journal of Clinical Pharmacology ·Suresh Mallikaarjun, Daniel E. Salazar, Steven L. Bramer	145
16	Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate 2004 ·The Journal of Clinical Pharmacology ·Leslie Citrome, Richard C. Josiassen, Nigel Bark, Daniel E. Salazar, Suresh Mallikaarjun	71
17	Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease 1999 ·Clinical Pharmacokinetics ·Steven L. Bramer, William P. Forbes, Suresh Mallikaarjun	63
18	Effect of Multiple Cilostazol Doses on Single Dose Lovastatin Pharmacokinetics in Healthy Volunteers 1999 ·Clinical Pharmacokinetics ·Steven L. Bramer, (unknown), A. Corey, Suresh Mallikaarjun	15
19	Effect of Renal Impairment on the Pharmacokinetics of Cilostazol and its Metabolites 1999 ·Clinical Pharmacokinetics ·Suresh Mallikaarjun, William P. Forbes, Steven L. Bramer	15
20	High-performance liquid chromatographic method for the determination of salicylic acid and its metabolites in urine by direct injection 1989 ·Journal of Chromatography B Biomedical Sciences and Applications ·Suresh Mallikaarjun, John H. Wood, H. Thomas Karnes	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact